Start an analysis for LGN
Legence Corp.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $150m | 30-Sep-26 | 10-Q filed 12-Nov-26 |
| Remaining authorization | $150mEST | 30-Sep-26 | 10-Q filed 12-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | Not found in filings | — | |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 10-Nov-26 | $150m | $150mEST | n/a | On November 10, 2026, the Board authorized a new $ 150.0 million share repurchase program, pursuant to which the Company may, from time to time, acquire shares of its Class A Common Stock in the open market10-Q filed 12-Nov-26 |
Open-market repurchases
None reported in the filings we hold.